A. BRIAN DAVIS - 08 Jan 2026 Form 4 Insider Report for Grace Therapeutics, Inc. (GRCE)

Role
Director
Signature
/s/ Robert DelAversano as attorney-in-fact for Brian Davis
Issuer symbol
GRCE
Transactions as of
08 Jan 2026
Net transactions value
$0
Form type
4
Filing time
12 Jan 2026, 16:01:33 UTC
Previous filing
13 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DAVIS A BRIAN Director C/O GRACE THERAPEUTICS, INC., 103 CARNEGIE CENTER, SUITE 300, PRINCETON /s/ Robert DelAversano as attorney-in-fact for Brian Davis 12 Jan 2026 0001184432

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRCE Stock Option (Right to Buy) Award $0 +10,000 $0.000000 10,000 08 Jan 2026 Common Stock 10,000 $3.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option vests on the date of grant and the remaining 75% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2026, subject to the Reporting Person's continuous service as of each vesting date.